Stockreport

Axovant Announces 6-Month Follow-Up Data From First Cohort of SUNRISE-PD Phase 2 Trial of AXO-Lenti-PD and Pipeline Update

Axovant Gene Therapies Ltd.  (AXGT) 
Last axovant gene therapies ltd. earnings: 2/10 06:00 am Check Earnings Report
PDF AXO-Lenti-PD was observed to be generally well tolerated at six months, and continued to demonstrate benefits in both patients across multiple measures after a single ad [Read more]